Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C4H4N2 |
| Molecular Weight | 80.088 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C1=CN=CC=N1
InChI
InChIKey=KYQCOXFCLRTKLS-UHFFFAOYSA-N
InChI=1S/C4H4N2/c1-2-6-4-3-5-1/h1-4H
| Molecular Formula | C4H4N2 |
| Molecular Weight | 80.088 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Reduction of in vivo lung metastases by dinuclear ruthenium complexes is coupled to inhibition of in vitro tumour invasion. | 2004-02 |
|
| Total synthesis of (+/-)-alantrypinone by hetero Diels-Alder reaction. | 2004-01-09 |
|
| Redox reactions of the pyranopterin system of the molybdenum cofactor. | 2004-01 |
|
| Anion control of the self-assembly of 2,3-diarylpyrazines with silver(I) salts. | 2003-12-29 |
|
| Symmetrical electron-deficient materials incorporating azaheterocycles. | 2003-11-21 |
|
| Dinuclear versus mononuclear ruthenium(II) and osmium(II) complexes as potent mediators of glucose oxidase; crystal structure of [OsCl(4,4'-bpy)(bpy)2]BF4. | 2003-11 |
|
| Pyrazine analogues of dipyrrolylquinoxalines. | 2003-10-30 |
|
| Synthesis and pharmacological evaluation of (Z)-9-(heteroarylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes: thiophene analogues as potent norepinephrine transporter inhibitors. | 2003-10-20 |
|
| Novel synthetic approach to 6,7-dihydro-5H-imidazo[1,5-a]-pyrazin-8-ones. | 2003-10-16 |
|
| Coordination polyhedron and chemical vapor deposition of Cu(hfacac)2(t-BuNH2). | 2003-10-06 |
|
| Growth and angiogenesis are inhibited in vivo in developing tissues by pyrazine and its derivatives. | 2003-10 |
|
| Generation of group-specific antibodies against sulfonamides. | 2003-09-24 |
|
| Long-range ferromagnetic ordering in two-dimensional coordination polymers Co[N(CN)2]2(L) [L = pyrazine dioxide (pzdo) and 2-methyl pyrazine dioxide (mpdo)] with dual mu- and mu3-[N(CN)2] bridges. | 2003-08-25 |
|
| Silver(I) coordination chemistry of 2,6-diarylpyrazines. Pi-stacking, anion coordination, and steric control. | 2003-08-25 |
|
| Capsule-like assemblies in polar solvents. | 2003-08-22 |
|
| Ferromagnetic ordering and metamagnetism in malonate bridged 3D diamond-like and honeycomb-like networks: [Cu(mal)(DMF)]n and [[Cu(mal)(0.5pyz)].H2O]n (mal = Malonate Dianion, DMF = N,N-dimethylformamide, pyz = Pyrazine). | 2003-08-11 |
|
| Semisynthesis of heterocyclic analogues of squamocin, a cytotoxic annonaceous acetogenin, by an unusual oxidative decarboxylation reaction. | 2003-08-05 |
|
| Extended quantum critical phase in a magnetized spin-1/2 antiferromagnetic chain. | 2003-07-18 |
|
| Synthesis, complexation, and coordination oligomerization of 1,8-pyrazine-capped 5,12-dioxocyclams. | 2003-07-14 |
|
| Synthesis and properties of V6O16CU(C4H4N2)2 x (H2O)(0.22(1)): charge density matching of a metal-segregated layer structure. | 2003-07-14 |
|
| DOTTADs--readily made novel metal ligands with multivariant functionality--trans-DOTTADs and semi-DOTTADs. | 2003-06-21 |
|
| An overview of inhibitors of Na(+)/H(+) exchanger. | 2003-06 |
|
| Mechanisms responsible for the in vitro relaxation of ligustrazine on porcine left anterior descending coronary artery. | 2003-05-16 |
|
| Effects of heterocyclic aromatic substituents on binding affinities at two distinct sites of somatostatin receptors. Correlation with the electrostatic potential of the substituents. | 2003-05-08 |
|
| Chemoenzymatic synthesis of aroma active 5,6-dihydro- and tetrahydropyrazines from aliphatic acyloins produced by baker's yeast. | 2003-05-07 |
|
| Two-dimensional homochiral manganese(II)-azido frameworks incorporating an achiral ligand: partial spontaneous resolution and weak ferromagnetism. | 2003-04-30 |
|
| Chromophore-modified bisnaphthalimides: DNA recognition, topoisomerase inhibition, and cytotoxic properties of two mono- and bisfuronaphthalimides. | 2003-04-15 |
|
| Spontaneously organizing metal connectors as supramolecular structure directors of two- and three-dimensional organometallic assemblies. | 2003-04-14 |
|
| A study by ultraviolet spectroscopy on the self-association of diazines in aqueous solution. | 2003-04 |
|
| New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin. | 2003-03-27 |
|
| [Cu(H4C3N2S)Cl2](n), an unprecedented diazole-bridged one-dimensional copper halide: synthesis, structure, and magnetic properties. | 2003-03-24 |
|
| Novel pyrazine metabolites found in polymyxin biosynthesis by Paenibacillus polymyxa. | 2003-03-14 |
|
| Assembly of discrete, one-, two-, and three-dimensional silver(I) supramolecular complexes containing encapsulated acetylide dianion with nitrogen-donor spacers. | 2003-03-10 |
|
| Infrared activity of symmetric bridging ligand modes in pyrazine-bridged hexaruthenium mixed-valence clusters. | 2003-02-24 |
|
| Synthesis, biological evaluation and DNA binding properties of novel mono and bisnaphthalimides. | 2003-02-21 |
|
| Estrogenic diazenes: heterocyclic non-steroidal estrogens of unusual structure with selectivity for estrogen receptor subtypes. | 2003-02-20 |
|
| Synthesis, structure-activity relationship and in vitro evaluation of coelenterazine and coelenteramine derivatives as inhibitors of lipid peroxidation. | 2003-02 |
|
| A guest-induced assembly of a molecular box from methylcobaloxime and 1, 4-phenylenebisboronic acid. | 2003-01-27 |
|
| In situ co-crystallisation as a tool for low-temperature crystal engineering. | 2003-01-21 |
|
| X- and W-band EPR and Q-band ENDOR studies of the flavin radical in the Na+ -translocating NADH:quinone oxidoreductase from Vibrio cholerae. | 2003-01-08 |
|
| Augmentation of H2 photoproduction in Rhodopseudomonas palustris by N-heterocyclic aromatic compounds. | 2003-01 |
|
| Preparing functional bis(indole) pyrazine by stepwise cross-coupling reactions: an efficient method to construct the skeleton of dragmacidin D. | 2002-12-27 |
|
| Synthesis and antimycobacterial activity of pyrazine and quinoxaline derivatives. | 2002-12-05 |
|
| Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity. | 2002-12 |
|
| 2-pyrazinylnitrene and 4-pyrimidylnitrene. Ring expansion to 1,3,5-triazacyclohepta-1,2,4,6-tetraene and ring opening to (2-Isocyanovinyl)carbodiimide. | 2002-11-29 |
|
| Synthesis of a new antischistosomally active and toxicologically tolerant C-12 monothione surrogate of the universal antihelmintic praziquantel. | 2002-10-31 |
|
| Solid-state ligand dynamics in interpenetrating Mn[N(CN)(2)](2)(pyrazine): a neutron spectroscopy study. | 2002-10-23 |
|
| Kinetics and mechanism of the formation of nitroprusside from aquapentacyanoferrate(III) and NO: complex formation controlled by outer-sphere electron transfer. | 2002-10-21 |
|
| Volatile compounds of headspace gas in the Japanese fish sauce ishiru. | 2002-10 |
|
| Amitriptyline has a dual effect on the conductive properties of the epithelial Na channel. | 2002-10 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:44:41 GMT 2025
by
admin
on
Mon Mar 31 18:44:41 GMT 2025
|
| Record UNII |
2JKE371789
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
JECFA EVALUATION |
PYRAZINE
Created by
admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000045822
Created by
admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
|
PRIMARY | |||
|
9261
Created by
admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
|
PRIMARY | |||
|
400221
Created by
admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
|
PRIMARY | |||
|
206-027-6
Created by
admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
|
PRIMARY | |||
|
30953
Created by
admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
|
PRIMARY | |||
|
2JKE371789
Created by
admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
|
PRIMARY | |||
|
PYRAZINE
Created by
admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
|
PRIMARY | |||
|
m9338
Created by
admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
|
PRIMARY | Merck Index | ||
|
290-37-9
Created by
admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
|
PRIMARY | |||
|
DTXSID8049410
Created by
admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
|
PRIMARY | |||
|
728
Created by
admin on Mon Mar 31 18:44:41 GMT 2025 , Edited by admin on Mon Mar 31 18:44:41 GMT 2025
|
PRIMARY |